A multicenter, double-blind, randomized trial of ziprasidone (80 - 160 Mg) versus olanzapine (10 - 20 Mg) in patients with recent-onset schizophrenia, schizoaffective and schizophreniform disorder

Trial Profile

A multicenter, double-blind, randomized trial of ziprasidone (80 - 160 Mg) versus olanzapine (10 - 20 Mg) in patients with recent-onset schizophrenia, schizoaffective and schizophreniform disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2011

At a glance

  • Drugs Olanzapine; Ziprasidone
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2011 Results published in the Schizophrenia Bulletin.
    • 01 Jul 2010 Results have been published in Schizophrenia Research.
    • 14 Sep 2009 Results presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top